# Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors

> **NCT00676949** · PHASE1 · COMPLETED · sponsor: **Kyushu University** · enrollment: 18 (actual)

## Conditions studied

- Metastatic Tumors

## Interventions

- **BIOLOGICAL:** 5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1

## Key facts

- **NCT ID:** NCT00676949
- **Lead sponsor:** Kyushu University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2011-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676949, "Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00676949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*